155 related articles for article (PubMed ID: 20956529)
1. Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1.
Zhou J; Liu Y; Zhang W; Popov VM; Wang M; Pattabiraman N; Suñé C; Cvekl A; Wu K; Jiang J; Wang C; Pestell RG
J Biol Chem; 2010 Dec; 285(51):40342-50. PubMed ID: 20956529
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of Forkhead signaling by the retinal determination factor DACH1.
Zhou J; Wang C; Wang Z; Dampier W; Wu K; Casimiro MC; Chepelev I; Popov VM; Quong A; Tozeren A; Zhao K; Lisanti MP; Pestell RG
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6864-9. PubMed ID: 20351289
[TBL] [Abstract][Full Text] [Related]
3. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
4. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
Popov VM; Zhou J; Shirley LA; Quong J; Yeow WS; Wright JA; Wu K; Rui H; Vadlamudi RK; Jiang J; Kumar R; Wang C; Pestell RG
Cancer Res; 2009 Jul; 69(14):5752-60. PubMed ID: 19605405
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer.
Chen K; Wu K; Gormley M; Ertel A; Wang J; Zhang W; Zhou J; Disante G; Li Z; Rui H; Quong AA; McMahon SB; Deng H; Lisanti MP; Wang C; Pestell RG
Oncotarget; 2013 Jun; 4(6):923-35. PubMed ID: 23798621
[TBL] [Abstract][Full Text] [Related]
6. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG
Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615
[TBL] [Abstract][Full Text] [Related]
7. Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax and Eya genes.
Heanue TA; Davis RJ; Rowitch DH; Kispert A; McMahon AP; Mardon G; Tabin CJ
Mech Dev; 2002 Feb; 111(1-2):75-87. PubMed ID: 11804780
[TBL] [Abstract][Full Text] [Related]
8. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.
Wu K; Liu M; Li A; Donninger H; Rao M; Jiao X; Lisanti MP; Cvekl A; Birrer M; Pestell RG
Mol Biol Cell; 2007 Mar; 18(3):755-67. PubMed ID: 17182846
[TBL] [Abstract][Full Text] [Related]
9. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.
Wu K; Chen K; Wang C; Jiao X; Wang L; Zhou J; Wang J; Li Z; Addya S; Sorensen PH; Lisanti MP; Quong A; Ertel A; Pestell RG
Cancer Res; 2014 Feb; 74(3):829-39. PubMed ID: 24335958
[TBL] [Abstract][Full Text] [Related]
10. DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.
Sundaram K; Mani SK; Kitatani K; Wu K; Pestell RG; Reddy SV
J Cell Biochem; 2008 Apr; 103(6):1747-59. PubMed ID: 17891780
[TBL] [Abstract][Full Text] [Related]
11. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.
Wu K; Yang Y; Wang C; Davoli MA; D'Amico M; Li A; Cveklova K; Kozmik Z; Lisanti MP; Russell RG; Cvekl A; Pestell RG
J Biol Chem; 2003 Dec; 278(51):51673-84. PubMed ID: 14525983
[TBL] [Abstract][Full Text] [Related]
12. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.
Wu K; Katiyar S; Witkiewicz A; Li A; McCue P; Song LN; Tian L; Jin M; Pestell RG
Cancer Res; 2009 Apr; 69(8):3347-55. PubMed ID: 19351840
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
[TBL] [Abstract][Full Text] [Related]
14. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
15. Dachshund binds p53 to block the growth of lung adenocarcinoma cells.
Chen K; Wu K; Cai S; Zhang W; Zhou J; Wang J; Ertel A; Li Z; Rui H; Quong A; Lisanti MP; Tozeren A; Tanes C; Addya S; Gormley M; Wang C; McMahon SB; Pestell RG
Cancer Res; 2013 Jun; 73(11):3262-74. PubMed ID: 23492369
[TBL] [Abstract][Full Text] [Related]
16. DACH1 suppresses breast cancer as a negative regulator of CD44.
Xu H; Yu S; Yuan X; Xiong J; Kuang D; Pestell RG; Wu K
Sci Rep; 2017 Jun; 7(1):4361. PubMed ID: 28659634
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor signaling regulates Dach1 expression during skeletal development.
Horner A; Shum L; Ayres JA; Nonaka K; Nuckolls GH
Dev Dyn; 2002 Sep; 225(1):35-45. PubMed ID: 12203718
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma.
Zhu H; Wu K; Yan W; Hu L; Yuan J; Dong Y; Li Y; Jing K; Yang Y; Guo M
Hepatology; 2013 Dec; 58(6):2012-22. PubMed ID: 23787902
[TBL] [Abstract][Full Text] [Related]
19. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1.
Lee JW; Kim HS; Kim S; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Park KM; Ryoo ZY; Lee S
Biochem Biophys Res Commun; 2012 Mar; 420(1):91-5. PubMed ID: 22405764
[TBL] [Abstract][Full Text] [Related]
20. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.
Cao A; Li J; Asadi M; Basgen JM; Zhu B; Yi Z; Jiang S; Doke T; El Shamy O; Patel N; Cravedi P; Azeloglu EU; Campbell KN; Menon M; Coca S; Zhang W; Wang H; Zen K; Liu Z; Murphy B; He JC; D'Agati VD; Susztak K; Kaufman L
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
